Peter Pancione Email & Phone Number

Nashville, Tn, Us

Nashville Metropolitan Area

Developing business and forging client relationships for this provider of integrated, harmonized and enriched Real World Data.

Greater Nashville

• Assisted in building Real World Evidence practice from scratch for consultancy to pharmaceutical companies.• Evaluated, selected, and maintained relationships with 18 RWE data supply companies so that Lumanity consultants could acquire data to enable client engagements for HEOR, medical affairs, and commercial clients.• Consulted on RWE topics for clients (billable) and for Lumanity consulting teams.• Performed extensive work educating Lumanity staff in RWE sources and uses.

Greater Nashville Area

• Conducted business development efforts for late-stage startup, bringing insights from laboratory and other data to pharmaceutical commercial and RWE challenges.• Closed over $5M in 2021, successfully adding new and win-back clients.• Worked with clients to align commercial strategies to prescriber decision making; guided clients in use of unique dataset to optimize sales representative efforts and digital advertising.

Chicago Metropolitan Area, United States

• Helped pharmaceutical companies target, execute, optimize, and measure HCP and direct-to-consumer advertising; focused primarily on TV and digital channels, including advanced targeting for programmatic buying.

Greater Chicago Area

• Partnered with dominant pharmacy chain to utilize IQVIA insights in their management and strategy formulation processes, thereby embedding IQVIA data and services into their operations.• Formulated and executed tactical plan to provide IQVIA data for client’s physician targeting and activity goals, leading to 25% client sales force expansion and client commitment to deliver $2B in incremental sales over five years.• Played pivotal role in acquiring data from major specialty pharmacy that had been previously unwilling to provide data to IQVIA. Collaborated with internal team to address needs of $20B provider of specialty pharmaceuticals to close agreement.• CEO Team Award Recipient - Provided leadership to one of ten teams selected globally for IQVIA’s highest recognition of outstanding performance and contribution.

Greater Chicago Area

Led $80M+ annual relationship between Abbott / AbbVie and IQVIA. Worked with client to optimize use of IQVIA insight in setting commercial strategies. Formulated strategic and tactical account plans for U.S. and Europe. Guided contract negotiations during AbbVie spin-off culminating in 92 agreements with total value of $166M.

Greater Chicago Area

Used IQVIA data and sophisticated decision support analytics to help clients make strategic decisions. Led decision analysis project for set of interrelated go / no-go development decisions for novel and bio-similar diabetes compounds, resulting in recommendations adopted by client senior executives; work led to investments in novel and bio-similar products. Managed deployment of newly developed probabilistic analysis-based approach to optimize promotional spending for launch product, leading to client implementation of key recommendations.

Greater Chicago Area

Guided clients in using recently launched anonymous patient longitudinal data product to enhance commercial strategy formulation and tactical execution of commercial plans.

Greater Chicago Area

Closed $1.3M in software and professional services revenue and grew pipeline from zero to $5.5M.

Greater Chicago Area

Grew territory from one to seven clients, increasing revenues by 500%.

Greater Chicago Area

Managed development of commercial strategy for top-two biopharmaceutical company. Worked with senior executives to articulate commercial vision and then define capabilities required to reach it. Led creation of U.S. market entry plan for top-five Japanese pharmaceutical company. Spearheaded blueprinting effort that translated CEO’s vision into specific business capabilities. Evaluated entry options and developed business case to gain Japanese CEO’s approval to build U.S. company. Led development of marketing plan for leading respiratory product’s entry into new therapeutic area.

Mba, Finance And Statistics

Ba, Economics

Phi Beta Kappa